Dr Esther Gan | Scientist, Nuevocor, Singapore
In this video, we chat with Dr Esther Gan, a Scientist at Nuevocor in Singapore, who shares her insights and experience in conducting medical research for a biopharmaceutical startup, and how the COVID-19 pandemic has been a catalyst for change in certain areas of research practice.
Noting the key driver of research integrity as the principle to do no harm and to positively impact society, she explains how research commercialisation helps ensure science is accessible and that the benefits aren’t obscured.
Shedding light on the research commercialisation ecosystem, Esther uses vaccine development as a timely analogy for the mutual dependence of ‘academic labs’ in universities and industry backers in producing solutions to global challenges.
How can we drive greater research commercialisation and what steps can institutions take? Watch the video to hear Esther’s perspective.
#turnitin #integritymatters #research #researchintegrity #publishing #researchcommercialisation